latest health care news

03.10.16

NICE to charge companies for drugs testing under new proposals

Pharmaceutical companies could face charges of up to £282,000 to have their medicines considered for use on the NHS, according to reports.

Proposals seen by the Sunday Times suggest that NICE, the body responsible for assessing new treatments for use on the NHS, is considering implementing charges of £99,000 - £282,000 for assessments, which companies will have to pay whether the bid is successful or not.

NICE currently funds its own clinical assessments, but is facing budget challenges as part of the £22bn deficit in the NHS.

Paul Catchpole, values and access director at the Association of the British Pharmaceutical Industry (ABPI), said: “The proposed flat-fee charges are the highest ever seen from any health technology assessment organisation in the world and the cost will be prohibitive for smaller companies and will also pose challenges for all companies in creating compelling business cases for launching medicines for smaller populations and for rarer diseases in the UK.

“This has the potential to create further inequalities in access to medicines for NHS patients.”

He said NICE should implement “considerable efficiency savings” instead of new charges.

The proposals are expected to be published soon as part of the Accelerated Access Review, a report into how the NHS can speed up access to innovative drugs.

A NICE spokesperson said the aim of the proposals was to “allow greater flexibility, ensure value for money for taxpayers, foster more productive relationships with industry and secure patient access to the very best services, technologies, devices and medicines”.

Have you got a story to tell? Would you like to become an NHE columnist? If so, click here.

Comments

There are no comments. Why not be the first?

Add your comment

 

national health executive tv

more videos >

featured articles

View all News

last word

Haseeb Ahmad: ‘We all have a role to play in getting innovations quicker’

Haseeb Ahmad: ‘We all have a role to play in getting innovations quicker’

Haseeb Ahmad, president of the Association of the British Pharmaceutical Industry (ABPI), sits down with National Health Executive as part of our Last Word Q&A series. Would you talk us throu more > more last word articles >

health service focus

View all News

comment

NHS England dementia director prescribes rugby for mental health and dementia patients

23/09/2019NHS England dementia director prescribes rugby for mental health and dementia patients

Reason to celebrate as NHS says watching rugby can be good for your mental ... more >
Peter Kyle MP: It’s time to say thank you this Public Service Day

21/06/2019Peter Kyle MP: It’s time to say thank you this Public Service Day

Taking time to say thank you is one of the hidden pillars of a society. Bei... more >

interviews

NHS dreams come true for Teesside domestic

17/09/2019NHS dreams come true for Teesside domestic

Over 20 years ago, a Teesside hospital cleaner put down her mop and took st... more >

the scalpel's daily blog

Providers are delivering – and here’s how

09/10/2019Providers are delivering – and here’s how

It has been a challenging few years for healthcare providers, yet they have continued to deliver high quality care despite the conditions. Adam Brimelow, director of comm... more >
read more blog posts from 'the scalpel' >

editor's comment

25/09/2017A hotbed of innovation

This edition of NHE comes hot on the heels of this year’s NHS Expo which, once again, proved to be a huge success at Manchester Central. A number of announcements were made during the event, with the health secretary naming the second wave of NHS digital pioneers, or ‘fast followers’, which follow the initial global digital exemplars who were revealed at the same show 12 months earlier.  Jeremy Hunt also stated that by the end of 2018 – the 70th birthday... read more >